Peritech Pharma

Specialty Pharmaceutical Products for the Anus and Rectum

Health Tech & Life Sciences
Non Active, Dec 2023 ceased to operate
Seed Herzliya Founded 2012
LinkedIn
Total raised
Last: Undisclosed
Stage
Seed
Founded
2012
Headcount
1
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

Peritech Pharma is a specialty pharmaceuticals development company focusing on products for the anal/rectal area. The company has secured its first commercial agreement for two of its over-the-counter products: PP-110 for hemorrhoids and PP-120 for anal itching. The deal, signed with Latam BD Group, includes local manufacturing and marketing in Brazil and 23 other countries in Central and South America, as well as the Caribbean. PP-110 is based on known and approved active ingredients (pramoxine HCl 1% and phenylephrine 0.25%), similar to other leading brands. Because of its delivery mechanism, PP-110 has a long-lasting effect, which was proven in a randomized clinical trial. Participants who used PP-110 gel once a day reported better results with respect to pain, itching, and bleeding compared to other participants who used a comparable drug with the same active ingredients three to four times per day.

Funding history · 1 round · — total

Date unknown
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Peritech Pharma?
Peritech Pharma is a specialty pharmaceuticals development company that focuses on products for the anal/rectal area.
What is the current operational status of Peritech Pharma?
Peritech Pharma is currently inactive, having ceased operations in December 2023.
Which countries has Peritech Pharma secured patents for?
In May 2019, Peritech Pharma was granted patents for its products in China and Russia.
What was Peritech Pharma's first commercial agreement for its products?
Peritech Pharma secured a commercial agreement with Latam BD Group for its over-the-counter products, PP-110 for hemorrhoids and PP-120 for anal itching. This deal includes manufacturing and marketing in Brazil and 23 other countries in Central and South America, and the Caribbean.
What were the results of the clinical trial for Peritech Pharma's PP-110 hemorrhoid treatment?
A randomized clinical trial showed that participants using Peritech Pharma's PP-110 gel once a day reported better results for pain, itching, and bleeding compared to those using a comparable drug with the same active ingredients three to four times daily.
When was Peritech Pharma founded?
Peritech Pharma was founded in March 2012.
What is the estimated employee count for Peritech Pharma?
Peritech Pharma has an estimated employee count of 1-10 individuals.
Who is a founder of Peritech Pharma?
Eran Eilat is a founder of Peritech Pharma.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 Patents

Tags

gynecologydrug-designpharmaceuticalsconsumerspatients